The agreement mainly focuses on expanding research on the technology to be used for the delivery of proton therapy and developing new protocols using protons to treat a wider range of cancer tumors.
Niek Schreuder, senior vice president of technology at ProCure, said: “By partnering with a world renowned academic institution that has a strong interest in furthering the use of proton therapy, we can significantly enhance the caliber of training programs at the Training and Development Center.”